Sign up to save your podcasts
Or
Share Diana V. Do, MD - Bringing Anti-VEGF Therapy into Focus: Comparing and Integrating Treatments for Retinal Vein Occlusion
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Diana V. Do, MD - Bringing Anti-VEGF Therapy into Focus: Comparing and Integrating Treatments for Retinal Vein Occlusion
Please visit answersincme.com/JZM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in retinal vein occlusion (RVO) discusses selecting among and incorporating anti-vascular endothelial growth factor (VEGF) therapy into treatment plans for patients with macular edema (ME) secondary to RVO. Upon completion of this activity, participants should be better able to: Evaluate the benefit-risk profiles of available anti-VEGF treatments for patients with macular edema secondary to RVO; Discuss practical approaches to optimally incorporate anti-VEGF agents into treatment plans for patients with RVO; and Apply strategies to counsel patients on the use of anti-VEGF agents for RVO to optimize patient outcomes.
View all episodes
By Answers in CMEPlease visit answersincme.com/JZM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in retinal vein occlusion (RVO) discusses selecting among and incorporating anti-vascular endothelial growth factor (VEGF) therapy into treatment plans for patients with macular edema (ME) secondary to RVO. Upon completion of this activity, participants should be better able to: Evaluate the benefit-risk profiles of available anti-VEGF treatments for patients with macular edema secondary to RVO; Discuss practical approaches to optimally incorporate anti-VEGF agents into treatment plans for patients with RVO; and Apply strategies to counsel patients on the use of anti-VEGF agents for RVO to optimize patient outcomes.